DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
6.90
0.06 (0.88%)
At close: Sep 26, 2025, 10:56 AM
0.88% (1D)
Bid | 6.88 |
Market Cap | 356.65M |
Revenue (ttm) | 13.8M |
Net Income (ttm) | -29.58M |
EPS (ttm) | -0.69 |
PE Ratio (ttm) | -10 |
Forward PE | -9.26 |
Analyst | Strong Buy |
Dividends | n/a |
Ask | 6.92 |
Volume | 16,520 |
Avg. Volume (20D) | 456,531 |
Open | 6.87 |
Previous Close | 6.84 |
Day's Range | 6.85 - 6.95 |
52-Week Range | 3.19 - 7.49 |
Beta | 1.40 |
Ex-Dividend Date | n/a |
About DMAC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DMAC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DMAC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-13.02%
DiaMedica Therapeutics shares are trading lower fo...
Unlock content with
Pro Subscription

1 month ago · seekingalpha.com
DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call TranscriptDiaMedica Therapeutics Inc. (NASDAQ:DMAC ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Dietrich John Pauls - President, CEO & Director Julie Krop - Chief Medical O...